AIG
URGN icon

American International Group’s UroGen Pharma URGN Stock Holding History

American International Group’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,664
Closed -$205K – 2593
2024
Q1 		$205K Buy
13,664
+143
+1% +$2.34K ﹤0.01% 2137
2023
Q4 		$203K Buy
13,521
+3,756
+38% +$48.8K ﹤0.01% 2167
2023
Q3 		$137K Buy
9,765
+348
+4% +$5.59K ﹤0.01% 2336
2023
Q2 		$97.5K Buy
+9,417
New +$104K ﹤0.01% 2591
2022
Q2 		– Sell
-9,685
Closed -$84K – 3268
2022
Q1 		$84K Sell
9,685
-682
-7% -$5.32K ﹤0.01% 2658
2021
Q4 		$99K Sell
10,367
-309
-3% -$4.36K ﹤0.01% 2723
2021
Q3 		$180K Sell
10,676
-254
-2% -$4.03K ﹤0.01% 2489
2021
Q2 		$167 Sell
10,930
-366
-3% -$6.62K ﹤0.01% 2624
2021
Q1 		$220 Buy
11,296
+29
+0.3% +$616 ﹤0.01% 2320
2020
Q4 		$203 Sell
11,267
-324
-3% -$6.79K ﹤0.01% 2283
2020
Q3 		$224K Sell
11,591
-262
-2% -$5.93K ﹤0.01% 2079
2020
Q2 		$310K Buy
11,853
+762
+7% +$18.6K ﹤0.01% 1854
2020
Q1 		$198K Sell
11,091
-642
-5% -$17.3K ﹤0.01% 1910
2019
Q4 		$392K Sell
11,733
-98
-0.8% -$2.67K ﹤0.01% 1832
2019
Q3 		$282K Sell
11,831
-82
-0.7% -$2.68K ﹤0.01% 1974
2019
Q2 		$428K Buy
+11,913
New +$439K ﹤0.01% 1786

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

American International Group's URGN Position: Q2 2024 in Review

American International Group sold out of UroGen Pharma (URGN) in Q2 2024, closing a stake of 13,664 shares — an estimated $205K sold.

American International Group first reported a position in URGN in Q2 2019 and held it in 16 quarters. The position peaked at $428K in Q2 2019. 115 funds tracked by Wall St. Rank hold URGN as of Q2 2024.

  • American International Group reported no remaining UroGen Pharma position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 13,664 UroGen Pharma shares in Q2 2024, an estimated $205K.
  • American International Group first reported a position in UroGen Pharma in Q2 2019 and held it in 16 quarters.
  • American International Group's UroGen Pharma position peaked at $428K in Q2 2019.
  • 115 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.